Nexplanon®: What Implanon® did next

Journal of Family Planning and Reproductive Health Care

Volumn 36, Issue 4, 2010, Pages 187-189

  Mansour, Diana ^a  

^a New Croft Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM SULFATE; ETHYLENE VINYL ACETATE COPOLYMER; ETONOGESTREL; NEXPLANON; PLACEBO; UNCLASSIFIED DRUG;

BIOEQUIVALENCE; CLINICAL TRIAL; DRUG IMPLANT; ECHOGRAPHY; HEALTH CARE PERSONNEL; HORMONAL CONTRACEPTION; HUMAN; NEEDLE; NEEDLESTICK INJURY; NOTE; PATIENT POSITIONING; POSTMARKETING SURVEILLANCE; QUALITY CONTROL; RADIOGRAPHY; SEXUAL HEALTH; TRAINING; ULTRAVIOLET RADIATION; UNITED KINGDOM;

EID: 78149304065     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118910793048629     Document Type: Note

References (12)

1. Department of Health. Statement on Contraception and Teenage Pregnancy. 5 February 2009. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/ Publichealth/Healthimprovement/Sexualhealth/DH-085686 [Accessed 10 July 2010].
2. National Institute for Health and Clinical Excellence. Long-acting Reversible Contraception (Clinical Guideline 30). 2005. http://guidance.nice. org.uk/CG30/NICEGuidance/pdf/English [Accessed 10 July 2010].
3. Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008; 13(Suppl. 1): 4-12. (Pubitemid 351364455)
4. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005; 71: 306-308. (Pubitemid 40410081)
5. Jaffer K, Whalen S. Self removal of Implanon®: a case report. J Fam Plann Reprod Health Care 2005; 3: 248.
6. Gwinnell E. Expulsion of Implanon®. J Fam Plann Reprod Health Care 2007; 33: 211.
7. Mansour D. UK provision for removal of non-palpable contraceptive implants. J Fam Plann Reprod Health Care 2009; 35: 3-4.
8. Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C, et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 2008; 34: 9-12.
9. Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J, et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34: 89-91.
10. Summary of Product Characteristics: Implanon 68mg implant for subdermal use. http://emc.medicines.org.uk [Accessed 10 July 2010].
11. Mansour D, Trueman G. Off-licence prescribing in contraception. J Fam Plann Reprod Health Care 2004: 30: 9-10.
12. e-Learning for Healthcare (e-LfH). Sexual & Reproductive Healthcare e-learning. http://www.e-lfh.org.uk/projects/e-srh/register.html [Accessed 10 July 2010].